Aeglea BioTherapeutics CEO Anthony Quinn's 2021 pay slips 10% to $2.6M
Aeglea BioTherapeutics reports 2021 executive compensation
By ExecPay News
Published: April 21, 2022
Aeglea BioTherapeutics reported fiscal year 2021 executive compensation information on April 21, 2022.
In 2021, three executives at Aeglea BioTherapeutics received on average a compensation package of $1.8M, a 14% decrease compared to previous year.
Average pay of disclosed executives at Aeglea BioTherapeutics
Anthony G. Quinn, Chief Executive Officer, received $2.6M in total, which decreased by 10% compared to 2020. 65% of Quinn's compensation, or $1.7M, was in stock awards. Quinn also received $332K in non-equity incentive plan, $560K in salary, as well as $30K in other compensation.
Leslie Sloan, Chief Operating Officer, received a compensation package of $1.4M, which increased by 16% compared to previous year. 57% of the compensation package, or $822K, was in stock awards.
Michael Hanely, Chief Operating Officer, earned $1.3M in 2021.
Related executives
You may also like
Source: SEC filing on April 21, 2022.